As of the end of December 2024, Objective held just under AUD 100 million in cash and cash equivalents and no debt. Objective’s business is also of exceptionally high-quality due to its government ...

Secure your brand’s future with Houston IP legal experts who transform complex trademark challenges into strategic growth ...

The global market for artificial intelligence-powered diagnostics, valued at $1.9 billion in 2024, is projected to surge to ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...